| 2023-02-03 | +98.9% | legal | SEC EDGAR | HSCS 8-K: 1.01, 3.02, 3.03 (SEC Filing) |
| 2024-05-17 | -48.2% | news | Seeking Alpha | Heart Test conducts 1-for-100 reverse stock split |
| 2023-09-18 | -48.2% | news | Seeking Alpha | Heart Test Laboratories files for $50M mixed shelf offering - filing |
| 2025-05-19 | +38.0% | legal | SEC EDGAR | HSCS 8-K: 3.01 and 8.01 (SEC Filing) |
| 2023-11-21 | +27.4% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2024-05-16 | -22.5% | earnings | MarketBeat | HeartSciences (HSCS) Stock Forecast and Price Target 2026 - MarketBeat |
| 2022-08-05 | +22.1% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2023-02-06 | -20.1% | news | Seeking Alpha | HeartSciences granted Israeli patent for ECG |
| 2023-11-27 | +18.2% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2023-11-28 | +17.6% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2023-09-21 | +17.4% | legal | SEC EDGAR | HSCS 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-08-04 | +17.4% | legal | SEC EDGAR | HSCS 8-K: 1.01 and (SEC Filing) |
| 2024-07-29 | -15.9% | news | Seeking Alpha | Heart Test Laboratories reports FY results |
| 2024-07-29 | -15.9% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2026-01-16 | +15.9% | legal | SEC EDGAR | HSCS 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2022-09-13 | +13.5% | earnings | Seeking Alpha | Heart Test Laboratories reports Q1 results |
| 2022-09-13 | +13.5% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2023-11-13 | +12.1% | legal | SEC EDGAR | HSCS 8-K: 1.01 and (SEC Filing) |
| 2023-01-11 | +11.7% | legal | SEC EDGAR | HSCS 8-K: 3.02 (SEC Filing) |
| 2025-07-30 | -11.6% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2022-11-07 | -11.1% | news | Seeking Alpha | Heart Test Laboratories (HSCS) Presents At LD Micro 15th Annual Main Event Conference - Presentation |
| 2025-08-22 | -10.9% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2023-12-06 | -10.4% | legal | SEC EDGAR | HSCS 8-K: 1.01 (SEC Filing) |
| 2024-06-05 | +10.3% | news | Seeking Alpha | Heart Test Laboratories regains compliance with Nasdaq listing requirements |
| 2025-09-11 | -10.0% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2023-12-14 | +9.5% | earnings | Seeking Alpha | Heart Test Laboratories reports Q2 results |
| 2023-12-14 | +9.5% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2022-06-23 | +9.3% | legal | SEC EDGAR | HSCS 8-K: 1.01, 5.03 (SEC Filing) |
| 2023-11-17 | +9.2% | legal | SEC EDGAR | HSCS 8-K: 1.01, 1.02, 3.02, 3.03 (SEC Filing) |
| 2025-12-16 | -9.2% | legal | SEC EDGAR | HSCS 8-K: 1.01 and (SEC Filing) |
| 2024-01-25 | +9.1% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2025-12-15 | -9.0% | earnings | Seeking Alpha | Heart Test Laboratories reports Q2 results |
| 2025-12-15 | -9.0% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2025-12-15 | -9.0% | earnings | Quiver Quantitative | HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions | HSCS Stock News - Quiver Quantitative |
| 2024-03-14 | +8.8% | earnings | Seeking Alpha | Heart Test Laboratories reports Q3 results |
| 2024-03-14 | +8.8% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2025-06-04 | -8.4% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2025-06-04 | -8.4% | legal | SEC EDGAR | HSCS 8-K: 1.01, 5.03 (SEC Filing) |
| 2025-06-04 | -8.4% | news | Intellectia AI | HSCS Forecast — Price Prediction for 2026. Should I Buy HSCS? - Intellectia AI |
| 2025-11-28 | -8.3% | legal | SEC EDGAR | HSCS 8-K: 3.02, 5.02 (SEC Filing) |
| 2023-07-19 | -7.7% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2022-12-16 | -7.5% | earnings | Seeking Alpha | Heart Test Laboratories GAAP EPS of -$0.22 beats by $0.01 |
| 2022-10-26 | +7.3% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2023-03-23 | -6.7% | legal | SEC EDGAR | HSCS 8-K: 3.01, 5.02 (SEC Filing) |
| 2022-06-24 | +6.6% | earnings | MarketBeat | HeartSciences (HSCS) Stock Price, News & Analysis - MarketBeat |
| 2024-09-12 | +6.4% | earnings | Seeking Alpha | Heart Test Laboratories GAAP EPS of -$2.64 misses by $0.18 |
| 2024-09-12 | +6.4% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2023-08-17 | -5.8% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2022-07-18 | -5.7% | legal | SEC EDGAR | HSCS 8-K: 3.02 (SEC Filing) |
| 2025-10-01 | +5.6% | legal | SEC EDGAR | HSCS 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2023-09-22 | +5.2% | legal | SEC EDGAR | HSCS 8-K: 1.01 and (SEC Filing) |
| 2026-04-08 | -5.0% | news | Xã Châu Thành | Can HeartSciences (HSCS) Stock Reach New Highs | Price at $2.29, Up 0.66% - Volume Leaders - Xã Châu Thành |
| 2026-04-06 | -4.9% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is HeartSciences (HSCS) Stock Slowing Down | Price at $2.26, Down 1.74% - Risk Reward Ratio - Cổng thông tin điện tử Tỉnh Sơn La |
| 2023-05-05 | +4.1% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for HeartSciences Inc. (HSCS) - Zacks Investment Research |
| 2025-07-14 | -4.1% | legal | SEC EDGAR | HSCS 8-K: 1.01, 5.02, 8.01 (SEC Filing) |
| 2023-01-03 | -3.9% | legal | SEC EDGAR | HSCS 8-K: 5.02 (SEC Filing) |
| 2024-06-04 | -3.8% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2026-03-25 | -3.7% | news | GlobeNewswire | HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category |
| 2026-04-15 | +3.5% | news | UBND thành phố Hải Phòng | HeartSciences (HSCS) Stock: Why Options Traders Watch It (Marginal Gain) 2026-04-15 - Stock Surge - UBND thành phố Hải Phòng |
| 2023-09-14 | +3.4% | earnings | Seeking Alpha | Heart Test Laboratories reports Q1 results |
| 2023-09-14 | +3.4% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2022-11-09 | -3.3% | analyst | ChartMill | HSCS Forecast, Price Target & Analyst Ratings | HEARTSCIENCES INC (NASDAQ:HSCS) - ChartMill |
| 2024-02-12 | -3.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2023-12-05 | -3.3% | earnings | Seeking Alpha | Heart Test stock rallies 27% on FDA update for MyoVista submission |
| 2025-10-21 | -3.3% | news | Yahoo Finance | HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance |
| 2025-10-21 | -3.3% | news | Zacks Investment Research | Should I buy HeartSciences Inc. (HSCS) - Zacks Investment Research |
| 2026-03-20 | -3.2% | earnings | ACCESS Newswire | Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26) |
| 2025-04-25 | +3.0% | news | Stock Titan | HSCS Stock Price, News & Analysis - Stock Titan |
| 2026-04-14 | -2.5% | news | GlobeNewswire | HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting |
| 2026-04-14 | -2.5% | news | Stock Titan | HeartSciences shareholders have until April 29 to vote online - Stock Titan |
| 2024-09-10 | -2.5% | legal | SEC EDGAR | HSCS 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-07-24 | +2.4% | news | Seeking Alpha | Heart Test Laboratories reports FY results |
| 2025-07-24 | +2.4% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2023-09-07 | -2.4% | legal | SEC EDGAR | HSCS 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2023-03-13 | -2.4% | legal | SEC EDGAR | HSCS 8-K: 1.01, 3.02 (SEC Filing) |
| 2022-09-09 | +2.4% | legal | SEC EDGAR | HSCS 8-K: 1.01, 3.02, 3.03 (SEC Filing) |
| 2023-02-22 | -2.4% | legal | SEC EDGAR | HSCS 8-K: 3.02 and (SEC Filing) |
| 2026-04-03 | -2.2% | legal | SEC EDGAR | HSCS 8-K: 5.02 (SEC Filing) |
| 2026-04-03 | -2.2% | executive | Stock Titan | HeartSciences (HSCS) announces death of COO and director, affirms business plans - Stock Titan |
| 2024-12-16 | +2.2% | earnings | Seeking Alpha | Heart Test Laboratories GAAP EPS of -$2.27 beats by $0.21 |
| 2024-12-16 | +2.2% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2026-04-20 | -1.9% | news | Cổng thông tin điện tử tỉnh Tây Ninh | HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20 - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-20 | -1.9% | news | UBND thành phố Hải Phòng | HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20 - Social Investment Platform - UBND thành phố Hải Phòng |
| 2026-03-16 | +1.9% | news | GlobeNewswire | HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update |
| 2026-03-16 | +1.9% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2026-03-16 | +1.9% | news | Stock Titan | AI heart scans in the cloud: HeartSciences builds ECG marketplace for hospitals - Stock Titan |
| 2025-06-03 | +1.9% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2022-09-20 | -1.9% | news | Seeking Alpha | HeartSciences granted U.S patent for ECG assessment of heart |
| 2022-09-20 | -1.9% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2026-03-17 | -1.9% | earnings | Seeking Alpha | Heart Test Laboratories GAAP EPS of -$0.63 beats by $0.19 |
| 2025-09-12 | -1.7% | earnings | Seeking Alpha | HeartSciences GAAP EPS of -$1.58 |
| 2025-09-08 | +1.6% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2026-04-23 | +1.6% | earnings | UBND thành phố Hải Phòng | HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly. - Debt Refinancing - UBND thành phố Hải Phòng |
| 2026-04-23 | +1.6% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops Views - Direct Listing - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-23 | +1.6% | earnings | Xã Vĩnh Công | HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops Views - Special Dividend - Xã Vĩnh Công |
| 2025-03-13 | -1.5% | earnings | Seeking Alpha | Heart Test Laboratories reports Q3 results |
| 2025-03-13 | -1.5% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2024-08-21 | -1.5% | legal | SEC EDGAR | HSCS 8-K: 1.01, 3.03 (SEC Filing) |
| 2026-02-05 | +1.4% | news | GlobeNewswire | University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center |
| 2025-07-21 | -1.2% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2023-01-24 | +1.2% | legal | SEC EDGAR | HSCS 8-K: 1.01 and (SEC Filing) |
| 2024-12-17 | +1.0% | legal | SEC EDGAR | HSCS 8-K: 8.01 (SEC Filing) |
| 2024-03-05 | -1.0% | news | Seeking Alpha | Heart Test Laboratories files to sell 34.68M shares for holders |
| 2023-03-14 | -1.0% | legal | SEC EDGAR | HSCS 8-K: 3.02 and (SEC Filing) |
| 2022-12-22 | +0.9% | legal | SEC EDGAR | HSCS 8-K: 2.02 and (SEC Filing) |
| 2025-05-07 | -0.8% | news | Stock Titan | HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - Stock Titan |
| 2024-05-22 | -0.8% | legal | SEC EDGAR | HSCS 8-K: 8.01 and (SEC Filing) |
| 2026-01-29 | -0.7% | news | GlobeNewswire | Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals |
| 2023-03-16 | +0.7% | earnings | Seeking Alpha | Heart Test Laboratories GAAP EPS of -$0.16 beats by $0.02, revenue of $1.95M |
| 2023-03-16 | +0.7% | legal | SEC EDGAR | HSCS 8-K: 2.02, 5.02 (SEC Filing) |
| 2025-01-21 | -0.6% | legal | SEC EDGAR | HSCS 8-K: 3.02, 5.02 (SEC Filing) |
| 2026-03-24 | -0.2% | news | GlobeNewswire | HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings |
| 2026-03-24 | -0.2% | executive | Stock Titan | HeartSciences CEO to outline strategy in virtual investor meetings - Stock Titan |
| 2022-06-16 | — | legal | SEC EDGAR | HSCS 8-K: 1.01, 7.01, 8.01 (SEC Filing) |